Gastrografin®

 

(diatrizoate meglumine and diatrizoate sodium solution USP)

Gastrografin® (diatrizoate meglumine and diatrizoate sodium solution USP) is a palatable lemon-flavored, water-soluble iodinated radiopaque contrast medium for oral or rectal administration used for radiographic examination of segments of the gastrointestinal tract, particularly in cases in which barium examinations would be potentially risky. Gastrografin is also used for examinations for foreign bodies on the pharynx and esophagus and disorders of the swallowing mechanism.

Contact us


Please fill out the form below and we will get back to you.

Différents pays peuvent avoir mis en place des processus spécifiques pour traiter les signalements d’effets indésirables. Pour signaler un effet indésirable lié aux produits Bracco, vous pouvez trouver des contacts spécifiques et des informations en sélectionnant la page "Pharmacovigilance" de votre pays.

* En cochant cette case et en cliquant sur le bouton Soumettre de cette page, je certifie que je suis un professionnel de santé et autorise Bracco Imaging S.p.A., ou des parties agissant en son nom, à me contacter pour me fournir des informations concernant Bracco Imaging S.p.A., les produits et solutions, les invitations à des événements et des séminaires, les mises à jour du secteur et d’autres notifications. Je comprends que les informations que je fournis ne seront pas transmises à quiconque en dehors de Bracco Imaging S.p.A., à l’exception des agents ou représentants qui traitent cette demande.

Indications and Usage:

GASTROGRAFIN® (diatrizoate meglumine and diatrizoate sodium solution) is indicated for radiographic examination of the gastrointestinal tract, particularly in cases in which barium suspensions would be potentially risky as well as examinations for foreign bodies in the pharynx and esophagus and disorders of the swallowing mechanism. 

 

For additional information, please consult product monograph on Health Canada website: 

https://pdf.hres.ca/dpd_pm/00065640.PDF

 

IMPORTANT SAFETY INFORMATION:

Not for parenteral use; do not inject.  For oral or rectal administration only.  It should be kept in mind that serious or anaphylactoid reactions that may occur with intravascular administration of radiopaque contrast agents and are theoretically possible following administration by other routes.  Patients at increased risk include those with a history of a previous reaction to a contrast medium, patients with a known sensitivity to iodine per se, and patients with a known clinical hypersensitivity (bronchial asthma, hay fever and food allergies).